The 2025 Enforcement Landscape: Why Attorneys General Are Focusing on Intoxicating Hemp
In 2025, state attorneys general (AGs) are at the forefront of an aggressive wave of enforcement against intoxicating hemp products. With federal oversight lacking clear direction—and hemp-derived cannabinoids like delta–8, HHC, and THCP proliferating—AGs across the United States have filled the regulatory vacuum. Their primary tools? Unfair or Deceptive Acts or Practices (UDAP) statutes, cease-and-desist orders, and state-level settlement agreements that impose significant restrictions on multi-state cannabis and hemp brands.
This article analyzes recent AG enforcement trends, highlights common UDAP theories and settlement playbooks, and provides a compliance toolkit for brands navigating this fast-changing legal terrain.
H2: Why State AGs Are Targeting Intoxicating Hemp in 2025
The Federal Gap and State Response
The 2018 Farm Bill opened the door to legal hemp-derived cannabinoids, but with minimal guidance for regulating synthetic and psychoactive derivatives. Courts—including the 9th and 4th Circuits—have generally sided with industry arguments that such compounds are legal if derived from hemp and kept below 0.3% delta-9 THC. However, federal agencies like the FDA have not directly enforced against these products—leaving the field to state AGs, especially where youth use or health risks are implicated.
AG coalitions have also weighed in on cannabis policy issues, urging Congress to address intoxicating products and supporting individual state bans or restrictions.
H2: UDAP Actions: The Playbook for Delta‑8 and Synthetic Cannabinoid Enforcement
What Is UDAP and Why Does It Matter?
UDAP (Unfair or Deceptive Acts or Practices) statutes exist in nearly all states. While originally intended to protect consumers from fraud, these statutes are being leveraged to challenge allegedly misleading marketing, mislabeling, and deceptive product claims on hemp-derived cannabinoids.
Key UDAP Theories Used by State AGs in 2025:
- Mislabeling potency or contents (e.g., inaccurate milligram/THC claims).
- Child-appealing flavors, packaging, or marketing.
- Failure to provide or forge batch-level Certificates of Analysis (COAs).
- Selling to minors or insufficient online age-gating.
- Unsubstantiated health/impairment claims or omission of impairment warnings.
Recent Enforcement Example: Nebraska AG Crackdown
In March 2025, Nebraska's Attorney General Mike Hilgers launched a sweeping action against delta-8 and synthetic THC products, issuing cease-and-desist letters to more than 100 Omaha-area retailers. The AG cited findings that over 90% of products tested failed labeling accuracy or compliance checks, with several targeting minors through flavor and packaging.
AG Hilgers offered settlement agreements requiring:
- Immediate removal of non-compliant products
- Revised labeling and COA transparency for all remaining inventory
- Restrictions on marketing and in-store displays
Other AGs in states including Florida, Indiana, and Texas have followed suit with warnings, product seizures, or direct enforcement focused on similar UDAP violations.
H2: What Multistate Brands Face: Settlements, Age-Gates, Labeling & Penalties
The Real Risks for National Hemp Operators
For multistate brands, an AG investigation now often leads to settlement orders with far-reaching impacts:
- Product Bans: Immediate withdrawal of SKUs or categories (e.g., delta-8, THCP, high-dose edibles).
- Labeling and Testing Mandates: Compelled adoption of stricter labeling—including batch-specific QR codes linking to third-party COAs, ingredient disclosures, and potency verification (see Florida SB 1676, 2025).
- Age-Gate and Marketing Restrictions: Requirements for robust, third-party online age verification (beyond pop-ups or honor systems), prohibition of child-friendly images or flavors, and limits on advertising placement.
- Civil Penalties and Monitoring: Settlement payments, ongoing compliance monitoring, and consent to random product testing.
Brands must be prepared to respond to AG inquiries within tight windows—sometimes under 2 weeks—often including an immediate product hold and document production demands.
Preemptive Steps to Minimize Enforcement Risk
1. Audit All Product Labels and COAs
- Align labeling and batch COA links with the strictest state’s standards (such as Florida’s packaging and QR code rules). Ensure every product batch is traceable, with updated COAs from accredited labs.
2. Implement True Age Verification
- In 2025, regulators now expect third-party age verification at point of sale—especially online. Review and upgrade your e-commerce flows—mere honor systems or pop-up confirmation checks are non-compliant (see 2025 best practices).
3. Cut Child Appeal: Review Flavors, Imagery, and Ad Placements
- AG settlements often require removal of candy, snack, or soda-style branding, cartoon imagery, or sweet-flavored products reminiscent of kids’ snacks. Make marketing and product imagery “adult appropriate.”
4. Add Impairment and Safety Disclaimers
- Update all labels and online product pages to include warnings about psychoactive effects, delayed onset, and impairment. This undercuts potential UDAP claims regarding omission of material facts.
5. Develop an AG Letter Response Playbook
- Prepare a rapid response workflow: designate in-house or external compliance counsel, appoint a documentation officer, and maintain real-time inventory/product test records. Practice response protocols—delays can result in summary product bans or lawsuits.
H2: What to Expect in 2025 and Beyond
Intoxicating hemp products remain a policy flashpoint as federal lawmakers continue to debate Farm Bill reforms and regulators spar over the boundary between "cannabis" and "hemp." In the meantime, expect:
- Further coordinated AG actions—including multistate investigation coalitions.
- Enforcement waves tied to school starts, legislative deadlines, and high-profile overdoses/incidents.
- Legislative stiffening of age-gate, packaging, and product class restrictions—particularly as states like Florida, Texas, and Indiana roll out updated compliance regimes.
Compliance for multi-state brands is no longer about minimum federal standards. It’s about meeting the most robust requirements across all relevant states—a moving target in 2025 as AGs use UDAP theories to push the outer edge of hemp enforcement.
Key Takeaways for Businesses and Consumers
- Brands must be audit-ready and faster than ever at responding to state AGs. Proactive compliance is far less costly than a post-enforcement settlement.
- Consumers should look for products with full COA transparency, robust age gates, and clear impairment warnings.
- Regardless of your footprint, “wait and see” is not a strategy—businesses must adapt to the strictest state and prepare for surprise scrutiny.
For tailored, up-to-the-minute guidance and operational resources on cannabis compliance, multi-state licensing, and hemp regulation, rely on CannabisRegulations.ai—your trusted partner in a fast-shifting regulatory landscape.